Advisory firm sets up elsNetwork for benchmarking commercial practices
TGaS Advisors (East Norriton, PA), which has been providing benchmarking and related consulting services focused on commercial operations in pharma for the past decade, is organizing a new network, to be called elsNetwork, targeted at young life sciences firms. “We recognized an unmet need in the emerging and pre-commercial market for our services, which led us to the launch of the new network,” says the company. Already, 15 firms have signed on and TGaS expects it to grow to 50 in the first year.
TGaS has an uncommon focus among consulting firms serving biopharma: most of its work is exclusively in commercial operations, including marketing, market access/managed markets; sales, sales operations, market research, marketing operations and sales training. It polls members routinely in these practice areas, and then shares best-practices information within its client base. Starting in June, a new service called TGaS Insights will provide member companies with broader, self-driven access to selected benchmark data and expert advice. Eventually, there will be some cross-sharing between elsNetwork and TGaS’ base of Big Pharma clients.
The initiative is headed by Gary Warner, TGaS vice president.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.